Print Page  Close Window

Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2016 Annual Report on Form 10-K - PDF 2016 Annual Report on Form 10-K
Fact Sheet - PDF Fact Sheet
OSUR (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$16.55
Change (%)0.00 (0.00%)
Volume200
Data as of 11/21/17 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
11/02/17OraSure Technologies to Present at the 2017 Canaccord Genuity Medical Technologies & Diagnostics Forum
BETHLEHEM, Pa., Nov. 02, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 2017 Canaccord Genuity Medical Technologies and Diagnostics Forum.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on November 9, 2017, at approximately 8:00 AM Eastern ... 
Printer Friendly Version
11/01/17OraSure Announces 2017 Third Quarter Financial Results
BETHLEHEM, Pa., Nov. 01, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and nine months ended September 30, 2017. Financial Highlights Consolidated net revenues for the third quarter of 2017 were $42.3 million, a 31% increase from the third quarter of 2016. Consolidated net product revenues were $41.2 million, representing a 62% ... 
Printer Friendly Version
11/01/17OraSure Technologies to Present at the Stephens 2017 Fall Investment Conference
BETHLEHEM, Pa., Nov. 01, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Stephens 2017 Fall Investment Conference.  The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on November 8, 2017, at approximately 11:00 AM Eastern Time (8:00 AM Pacific Time... 
Printer Friendly Version
10/11/17OraSure Technologies Earnings Conference Call Invitation
2017 Third Quarter Earnings Conference Call Wednesday, November 1, 2017, 5:00 p.m. ET BETHLEHEM, Pa., Oct. 11, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2017 third quarter financial results, 2017 fourth quarter financial guidance and certain business developments for 5:00 p.m. ET (2:00 p.m. PT) on Wednesday, November 1, 2017.  November 1, 2017 Schedule 4:00 p.m. ET 2017 third qua... 
Printer Friendly Version
Upcoming EventsMore >>
There are currently no events scheduled.
Data provided by Nasdaq. Minimum 15 minutes delayed. View Attributions and Sources